ArticleCellular and molecular life sciences : CMLS2026
A dual topology of STIM1 at the plasma membrane regulates calcium constitutive entry.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
STIM1, a type I transmembrane protein characterized by its extracellular N-terminal domain (STIM1PM), was initially identified as a plasma membrane (PM)-localized protein with tumor growth suppressor activity. Subsequent studies have identified a role for STIM1PM in the regulation of store-independent Ca2+ entry pathways including arachidonic acid-regulated Ca2+ (ARC) channels and constitutive Ca2+ entry (CCE). Mechanistically, N-glycosylation facilitates STIM1PM trafficking and stability at the PM. In this study, we demonstrate that STIM1PM uniquely exhibits dual topology at the PM, presenting both the expected type I orientation and an alternative type II orientation. Notably, we found that both orientations of STIM1PM contribute to CCE regulation. Our results confirm that N-glycosylation promotes the N-terminal-out orientation of STIM1PM, however, here we found it also modulates it’s the receptor’s dual topology. Our findings reveal that STIM1PM displays dual topology and regulate CCE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.